asa glp 1 recommendations GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become Holding GLP-1 Agonists Prior to

Patients should consult experienced healthcare providers to discuss the risks, benefits, and long-term safety of GLP-1 medication

Quality varies significantly, and patients need to evaluate potential sources carefully

Like semaglutide, tirzepatide does not independently affect the safety of donated blood

Symptoms of kidney dysfunction include decreased urine output, dark or blood in the urine, tiredness/fatigue, and high blood pressure

These limitations underscore the need for longer-term, more detailed studies to fully understand semaglutides role in joint health and musculoskeletal outcomes

This is highly illegal (using an AI generated doctor image and quote)